Loading report…
NVDANasdaqSEC filerUS GAAPSemiconductors & Related DevicesFiscal year ends January 31Reports in USD (US Dollar)
FY2026 · ended Jan 25, 2026
Normalization v8 · calculations ratios_v2 · data version 2 · report generated Oct 7, 2026. Source: SEC EDGAR XBRL company facts.
Select a figure to see its source filing and exact value.
| Ratio | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | |||||||||||||||
| Revenue growth | |||||||||||||||
| Operating income growth | |||||||||||||||
| Net income growth | |||||||||||||||
| Diluted EPS growth | |||||||||||||||
| Free cash flow growth | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | |||||
| Revenue CAGR (3 yr) | |||||||||||||||
| Revenue CAGR (5 yr) | —not available | ||||||||||||||
| Profitability | |||||||||||||||
| Gross margin | |||||||||||||||
| Cash flow & investment | |||||||||||||||
| Free cash flow margin | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | ||||||
| Balance sheet | |||||||||||||||
| Debt / equity | —not available | ||||||||||||||
| Working capital & shares | |||||||||||||||
| Inventory growth | |||||||||||||||
Select a ratio to see its formula, the exact inputs and periods used, and their source filings. — means an input is missing or the ratio is not meaningful (e.g. a negative denominator).
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Cost of revenue | |||||||||||||||
| Gross profit | |||||||||||||||
| Research & development | |||||||||||||||
| Selling, general & administrative | |||||||||||||||
| Operating income | |||||||||||||||
| Interest expense | r (restated) | r (restated) | |||||||||||||
| Income before taxes | |||||||||||||||
| Income tax expense | r (restated) | ||||||||||||||
| Net income | |||||||||||||||
| Diluted EPS | s | ||||||||||||||
| Diluted weighted-average shares |
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & cash equivalents |
| Line item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow |
Mechanical forecasts of reported revenue from NVIDIA CORP's own SEC filings. Each was recorded in FinSavoir's prediction ledger when it was issued and is never edited; it will be scored when the company reports the period. They say nothing about business prospects beyond the past pattern of revenue.
Not drawn: Average growth (drift) (models more than 3× away from the latest reported value start hidden to keep the scale readable). Tick a model to draw it; every value is in the table.
Each forecast in the chart is listed below with a link to its ledger record.
| Target | Model | Forecast | 80% prediction interval | vs “same as last year” | Ledger record |
|---|---|---|---|---|---|
| FY20271 year ahead · ends Jan 25, 2027 | Same as last yearReference (benchmark) | $215.9B | Not shown: no evaluated error range | — | Record |
| Straight-line trend (legacy)Benchmark | $113.1B | Not shown: no evaluated error range | −47.6% | Record | |
| Damped trend (exponential smoothing)Challenger (not promoted) | $152.9B | Not shown: no evaluated error range |
naive_last_v1). Next year's revenue equals the latest year's.6724bdd9-522e-47bd-b838-7c11117d58fc in the ledger. It will be compared with the revenue first reported for FY2027, and with any later restatement.Every forecast FinSavoir issued for this company, newest first (the latest 22 of 22 are listed; each links to its full ledger record). A forecast is scored against the revenue first reported in the company's filing for that period, once that filing exists; a period ending is not enough. Superseded forecasts (replaced by a newer one for the same period and model) are kept unchanged and still scored.
How the models were evaluated, and results across all companies →
Withheld: Share count inconsistent with net income ÷ EPS · Diluted weighted-average shares
Share count inconsistent with net income ÷ EPS in 7 periods. Example: Diluted shares tagged as 606,732, but net income ÷ diluted EPS implies about 608,889,313 — a thousands/units tagging error in SEC data. Withheld.
Affected periods: FY2008, FY2009, Q1 FY2010, Q2 FY2010, Q3 FY2010, Q1 FY2011, Q2 FY2011
Adjusted for a stock split · Diluted EPS · 9 periods
Adjusted for a stock split in 9 periods. Example: Diluted EPS was retroactively adjusted for a stock split (×0.25); first reported 4.52, now 1.13.
FY2020, Q2 FY2021, Q3 FY2021, FY2021, Q1 FY2022, Q2 FY2024, Q3 FY2024, FY2024, Q1 FY2025
Adjusted for a stock split · Diluted weighted-average shares · 10 periods
Adjusted for a stock split in 10 periods. Example: Diluted weighted-average shares was retroactively adjusted for a stock split (×4); first reported 618,000,000.00, now 2,472,000,000.00.
FY2020, Q2 FY2021, Q3 FY2021, FY2021, Q1 FY2022, FY2023, Q2 FY2024, Q3 FY2024, FY2024, Q1 FY2025
Fiscal-year labels differ between filings
Filings disagree on fiscal-year labelling; using offset 0.
Restated in a later filing · Capital expenditure
Capital expenditure was restated from 29,068,000 to 29,000,000.
Q1 FY2015
Restated in a later filing · Depreciation & amortization · 3 periods
Restated in a later filing in 3 periods. Example: Depreciation & amortization was restated from 55,083,000 to 55,000,000.
Q1 FY2015, Q2 FY2015, Q3 FY2015
Restated in a later filing · Diluted EPS · 3 periods
Restated in a later filing in 3 periods. Example: Diluted EPS was restated from 2 to 0.
Q1 FY2017, Q2 FY2017, FY2023
Restated in a later filing · Dividends paid
Dividends paid was restated from 46,731,000 to 47,000,000.
Q1 FY2015
Restated in a later filing · Income tax expense · 6 periods
Restated in a later filing in 6 periods. Example: Income tax expense was restated from 70,264,000 to 70,000,000.
FY2014, Q1 FY2015, Q2 FY2015, Q3 FY2015, Q1 FY2017, Q2 FY2017
Restated in a later filing · Interest expense · 5 periods
Restated in a later filing in 5 periods. Example: Interest expense was restated from 10,443,000 to 10,000,000.
FY2014, Q1 FY2015, Q2 FY2015, Q3 FY2015, FY2015
Restated in a later filing · Inventory
Inventory was restated from 419,686,000 to 412,467,000.
FY2013
Restated in a later filing · Net income · 2 periods
Restated in a later filing in 2 periods. Example: Net income was restated from 196,000,000 to 208,000,000.
Q1 FY2017, Q2 FY2017
Restated in a later filing · Operating cash flow
Operating cash flow was restated from 309,000,000 to 319,000,000.
Q1 FY2017
Thousands/units tagging inconsistency · Diluted weighted-average shares · 7 periods
Thousands/units tagging inconsistency in 7 periods. Example: One filing tagged Diluted weighted-average shares as 549,574 and another as 549,574,000 (a thousands/units slip in SEC data). FinLens shows the latest value.
Q2 FY2010, Q3 FY2010, FY2010, Q3 FY2011, FY2011, Q1 FY2012, Q2 FY2012
Latest annual report
10-K · fiscal year ended Jan 25, 2026 · filed Feb 25, 2026
| Operating margin |
|---|
| Net margin |
|---|
| Return on equity |
|---|
| Return on assets |
|---|
| Effective tax rate |
|---|
| FCF conversion | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available |
|---|
| CapEx as % of revenue | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available | —not available |
|---|
| R&D as % of revenue |
|---|
| SG&A as % of revenue |
|---|
| Debt / assets | —not available |
|---|
| Liabilities / assets |
|---|
| Current ratio |
|---|
| Interest coverage |
|---|
| Equity / assets |
|---|
| Receivables growth |
|---|
| Diluted share count change |
|---|
| s (adjusted for a stock split) |
| r (restated) |
| s (adjusted for a stock split) |
| s (adjusted for a stock split) |
| s (adjusted for a stock split) |
| s (adjusted for a stock split) |
| Short-term investments | —not reported for this period |
|---|
| Accounts receivable |
|---|
| Inventory | r (restated) |
|---|
| Current assets |
|---|
| Total assets |
|---|
| Current liabilities |
|---|
| Total debt | —not reported for this period | d (derived: long term debt total) | d (derived: long term debt total) | d (derived: long term debt total) | d (derived: long term debt total) | d (derived: long term debt total) | d (derived: long term debt total) | d (derived: long term debt total + commercial paper) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) | d (derived: debt current + long term debt noncurrent) |
|---|
| Total liabilities | d (derived: Total liabilities & equity − shareholders equity (liabilities not tagged)) | d (derived: Total liabilities & equity − shareholders equity (liabilities not tagged)) | d (derived: Total liabilities & equity − shareholders equity (liabilities not tagged)) |
|---|
| Shareholders' equity |
|---|
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| Capital expenditure | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period |
|---|
| Free cash flow | d (derived: Operating cash flow − capital expenditure) | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | —not reported for this period | d (derived: Operating cash flow − capital expenditure) | d (derived: Operating cash flow − capital expenditure) | d (derived: Operating cash flow − capital expenditure) | d (derived: Operating cash flow − capital expenditure) | d (derived: Operating cash flow − capital expenditure) |
|---|
| Depreciation & amortization |
|---|
| Dividends paid |
|---|
| Share repurchases |
|---|
Select any figure for its source filing and exact value. d derived by FinSavoir (e.g. Q4 = fiscal year − nine months) · r restated in a later filing · s adjusted for a stock split · — not reported for that period · withheld = failed a data-quality check.
| −29.2% |
| Record |
| Average growth (drift)Challenger (not promoted) | $432.0B | Not shown: no evaluated error range | +100.0% | Record |
| Damped recent growthChallenger (not promoted) | $251.3B | Not shown: no evaluated error range | +16.4% | Record |
| FY20282 years ahead · ends Jan 25, 2028 | Same as last yearReference (benchmark) | $215.9B | Not shown: no evaluated error range | — | Record |
|---|---|---|---|---|---|
| Straight-line trend (legacy)Benchmark | $122.8B | Not shown: no evaluated error range | −43.2% | Record | |
| Damped trend (exponential smoothing)Challenger (not promoted) | $169.4B | Not shown: no evaluated error range | −21.5% | Record | |
| Average growth (drift)Challenger (not promoted) | $864.1B | Not shown: no evaluated error range | +300.2% | Record | |
| Damped recent growthChallenger (not promoted) | $292.4B | Not shown: no evaluated error range | +35.4% | Record |
Each forecast in the chart is listed below with a link to its ledger record.
| Target | Model | Forecast | 80% prediction interval | vs “same as last quarter” | Ledger record |
|---|---|---|---|---|---|
| Q3 FY20271 quarter ahead · ends Oct 25, 2026 | Same as last quarterReference (benchmark) | $96.2B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $104.5B | Not shown: no evaluated error range | +8.6% | Record | |
| Same quarter last yearChallenger (not promoted) | $57.0B | Not shown: no evaluated error range | −40.8% | Record | |
| Q4 FY20272 quarters ahead · ends Jan 25, 2027 | Same as last quarterReference (benchmark) | $96.2B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $124.9B | Not shown: no evaluated error range | +29.8% | Record | |
| Same quarter last yearChallenger (not promoted) | $68.1B | Not shown: no evaluated error range | −29.2% | Record | |
| Q1 FY20283 quarters ahead · ends Apr 26, 2027 | Same as last quarterReference (benchmark) | $96.2B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $149.7B | Not shown: no evaluated error range | +55.5% | Record | |
| Same quarter last yearChallenger (not promoted) | $81.6B | Not shown: no evaluated error range | −15.2% | Record | |
| Q2 FY20284 quarters ahead · ends Jul 26, 2027 | Same as last quarterReference (benchmark) | $96.2B | Not shown: no evaluated error range | — | Record |
| Same quarter last year × trailing growthChallenger (not promoted) | $176.4B | Not shown: no evaluated error range | +83.4% | Record | |
| Same quarter last yearChallenger (not promoted) | $96.2B | Not shown: no evaluated error range | 0.0% | Record |
naive_last_q_v1). Every future quarter equals the latest quarter.667021c7-8657-401c-a725-6d482c0678cc in the ledger. It will be compared with the revenue first reported for Q3 FY2027, and with any later restatement.| Q2 FY2028 |
| Same quarter last year × trailing growth |
| $176.4B |
| Awaiting period end |
| — |
| — |
| — |
| Record |
| Oct 2, 2026 | Q1 FY2028 | Same as last quarter | $96.2B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q1 FY2028 | Same quarter last year | $81.6B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q1 FY2028 | Same quarter last year × trailing growth | $149.7B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q4 FY2027 | Same as last quarter | $96.2B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q4 FY2027 | Same quarter last year | $68.1B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q4 FY2027 | Same quarter last year × trailing growth | $124.9B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q3 FY2027 | Same as last quarter | $96.2B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q3 FY2027 | Same quarter last year | $57.0B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | Q3 FY2027 | Same quarter last year × trailing growth | $104.5B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2028 | Same as last year | $215.9B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2028 | Straight-line trend (legacy) | $122.8B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2028 | Average growth (drift) | $864.1B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2028 | Damped recent growth | $292.4B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2028 | Damped trend (exponential smoothing) | $169.4B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2027 | Same as last year | $215.9B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2027 | Straight-line trend (legacy) | $113.1B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2027 | Average growth (drift) | $432.0B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2027 | Damped recent growth | $251.3B | Awaiting period end | — | — | — | Record |
| Oct 2, 2026 | FY2027 | Damped trend (exponential smoothing) | $152.9B | Awaiting period end | — | — | — | Record |